Atlas Trials

Dacarbazine and Carmustine in Metastatic Melanoma

Clinical trial NCT01692691 · TERMINATED

Trial details

NCT number
NCT01692691
Sponsor
Western Regional Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Melanoma Metastatic
Start date
2012-08-01
Primary completion
2014-10-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.